In2Bones offers a range of innovative products, including fully pre-sterilized devices and single-use instrument sets, that address the needs of healthcare practitioners for improved efficiency, surgical outcomes, and patient care. Their designs solve problems faced by legacy device lines, and they collaborate with industry leaders and surgeons to bring new product applications to market. In2Bones specializes in biomaterials and their product lines cover various areas such as hand and wrist, foot and ankle, and biologics. Surgeons benefit from better patient satisfaction, optimized scheduling, and cost reductions, while hospitals and distributors gain advantages like lower infection risk and optimized storage. The company's experienced team has strong ties to the surgical community and is committed to simplifying surgical actions and equipment management while ensuring patient and staff safety. In2Bones was acquired by ConMed in 2022 and is based in Memphis, Tennessee.